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Enhancers play a central role in precisely regulating
the expression of developmentally regulated genes.
However, the machineries required for enhancer-
promoter communication have remained largely
unknown. We have found that Ell3, a member of the
Ell (eleven-nineteen lysine-rich leukemia gene) family
of RNA Pol II elongation factors, occupies enhancers
in embryonic stem cells. Ell3’s association with
enhancers is required for setting up proper Pol II
occupancy at the promoter-proximal regions of
developmentally regulated genes and for the recruit-
ment of the super elongation complex (SEC) to these
loci following differentiation signals. Furthermore,
Ell3 binding to inactive or poised enhancers is essen-
tial for stem cell specification. We have also detected
the presence of Pol II and Ell3 in germ cell nuclei.
These findings raise the possibility that transcription
factors could prime gene expression by marking
enhancers in ES cells or even as early as in the
germ cell state.
INTRODUCTION
A full molecular understanding of how transcriptional networks
are regulated in a pluripotent stem cell, resulting in coordinated
differentiation into a complex organism, remains one of the
greatest challenges in biology. Enhancers play pivotal roles in
modulating gene expression in a tissue-specific pattern during
development and are renowned for their ability to communicate
with their associated genes from great distances. Physical inter-
action between an enhancer and a promoter has been proposed
to explain how an enhancer influences gene activation (Bulger
and Groudine, 2011).
Several factors, including cohesin and CTCF, have been
shown to be involved in this process. CTCF can serve either as
a barrier to protect a gene from position effect variegation or
as a blocker to prevent long-range enhancer-promoter interac-
tions (Engel et al., 2004; Noonan and McCallion, 2010; Wendt
and Peters, 2009). Most of what we know about cohesin and
gene expression involves the interplay of cohesin and CTCF144 Cell 152, 144–156, January 17, 2013 ª2013 Elsevier Inc.(Dorsett, 2011; Hadjur et al., 2009; Hou et al., 2010; Mishiro
et al., 2009; Nativio et al., 2009). Recently, a second class of
cohesin sites, without CTCF, was described. The presence of
Mediator together with cohesin at enhancers was proposed
to help bridge interactions between enhancer-bound transcrip-
tion factors and RNA Pol II at the core promoter of active genes
(Kagey et al., 2010).
In order to better predict and define the signatures of cis-regu-
latory elements and modifications functioning as enhancers,
genome-wide sequencing analyses of chromatin occupancy
and histone modifications have been used. The analysis of
genomic DNA has focused on the identification of clusters of
transcription factor motifs (Markstein and Levine, 2002) and re-
sulted in the identification of highly occupied target/transcribed
(HOT) regions on DNA functioning as enhancers (Gerstein
et al., 2010; Kvon et al., 2012; Moorman et al., 2006). Reduced
nucleosome occupancy has also been used as a signature for
enhancer identification (Khoueiry et al., 2010). Additionally,
genome-wide chromatin modification studies have uncovered
possible signatures for identifying enhancers. More than
100,000 putative enhancers can be identified in the human
genome by combining the histone modifications and transcrip-
tional coactivator p300 (Creyghton et al., 2010; Heintzman
et al., 2009). For example, the presence of p300, H3K4me1,
and H3K27ac is proposed to mark active enhancers, whereas
p300 with H3K4me1 alone or with H3K27me3 mark poised or
inactive enhancers (Creyghton et al., 2010; Heintzman et al.,
2009; Rada-Iglesias et al., 2011). Recent studies have demon-
strated that Trr (in Drosophila) and MLL3/4 COMPASS-like
complexes (in mammalian cells) are essential for enhancer
function and monomethylation/acetylation (Herz et al., 2012).
Fundamental transcriptional studies over the past decade
have pointed to the elongation stage of transcription as a major
regulatory step in controlling gene expression (Levine, 2011;
Sims et al., 2004; Smith et al., 2011a; Smith and Shilatifard,
2010). In embryonic stem (ES) cells, many developmentally
regulated genes have paused Pol II at their promoters (Core
et al., 2008; Guenther et al., 2007; Rahl et al., 2010). Many of
these genes carry a bivalent chromatin mark consisting of both
H3K4 and H3K27 trimethylation status (Bernstein et al., 2006;
Mikkelsen et al., 2007). Recent studies classifying active and
poised enhancers have shown that, in ES cells, genes neigh-
boring H3K27me3-marked enhancers are enriched for this
bivalent chromatin mark and have lower expression than genes
associated with active enhancers (Rada-Iglesias et al., 2011).
Although the available genome-wide data have been success-
fully used to categorize enhancers and promoters into a limited
number of predictive states, how these different classes of
enhancers are used to regulate developmental gene expression
is largely unknown.
Recently, we identified an elongation complex named the
super elongation complex (SEC), comprised of the ELL family
of RNA Pol II elongation factors, ELL1-3, many of the most
frequent MLL translocation partners, and the positive transcrip-
tion elongation factor P-TEFb (Lin et al., 2010; Luo et al., 2012).
Individual ELL family members can have distinct cellular roles
within different forms of SEC (Luo et al., 2012). For example, in
mouse ES cells, Ell2 has a prominent role as a component of
SEC in the rapid yet synchronous activation of genes in response
to extracellular signals in the presence or absence of paused
Pol II (Lin et al., 2011). In contrast, in addition to its association
within SEC, Ell1 is also a component of the little elongation
complex (LEC) involved in small nuclear RNA (snRNA) gene
expression in ES cells (Smith et al., 2011b). ELL3 was originally
discovered as a Pol II elongation factor enriched in testis, and
sequence alignment indicated that ELL3 is more divergent
from ELL1 and ELL2 (Miller et al., 2000).
Here, we report a unique role for Ell3 at enhancers for the
priming of gene activation during stem cell specification. Ell3
occupies enhancers that are in a poised, active, or inactive state.
Ell3 is required for establishing proper Pol II occupancy at devel-
opmentally regulated genes in a cohesin-dependent manner
and is required for priming these genes for later recruitment of
SEC for transcriptional activation during differentiation. Ell3
and RNA Pol II seem to be preloaded on germ cell chromatin,
which may indicate that Ell3 could prime gene activation by
marking enhancers as early as in the germ cells.
RESULTS
Ell3 Occupies Enhancer Regions in Mouse Embryonic
Stem Cells
In order to further understand the functional diversity of the Ell
family of proteins, we mapped the genome-wide distribution
of Ell3 in mouse embryonic stem cells by ChIP-sequencing
(ChIP-seq). In contrast to the enrichment of Ell1 mostly at snRNA
genes and Ell2 at other highly transcribed genes in ES cells, Ell3
is preferentially found at intergenic regions in these cells (Fig-
ure S1A available online). We identified 5,253 high-confidence
regions bound by Ell3 with an FDR <0.05. The analyses of
peak distributions show that the majority of Ell3 peaks are
located long distances (more than 10 kb) from the core promoter
regions (Figures 1A and 1B). Examination of well-characterized
enhancers, such as the Sox2 and Lefty1 enhancers, shows
co-occupancy of Ell3 with known enhancer-binding factors,
including p300 and Oct4 (Figure 1C).
In order to investigate whether Ell3 is generally associated
with enhancers in ES cells, we analyzed the co-occurrences of
p300, H3K4me1, and H3K4me3 at Ell3-bound sites (Figure 1D).
The majority (90%) of these high-confidence Ell3 sites are
enriched for the enhancer markers p300 and H3K4me1, with
only10%overlapping with transcription start site (TSS) regionshighly occupied byH3K4me3 (Figures 1D–1F), indicating a global
association of Ell3 with enhancers. We find that Ell3 can co-
occur with H3K27ac on active enhancers and with H3K27me3
on poised or inactive enhancers (Figure S1B). However, there
is another class of Ell3-bound putative enhancers that do not
have either H3K27ac or H3K27me3; genes associated with
this class of enhancers have an intermediate level of expression
(Figure S1B, column 3). Gene ontology analysis of the nearest
genes to the non-TSS Ell3 peaks demonstrates that many of
these genes are involved in developmental processes, including
stem cell development, primary neural tube formation, embry-
onic pattern specification, and regulation of myeloid leukocyte
differentiation (Figures 1G and S1C).
Ell3 Binding to Enhancers Is Required for the Expression
of a Subset of Neighboring Genes
To identify genes that are regulated by Ell3, we performed total
RNA-sequencing (RNA-seq) analyses following short hairpin
RNA (shRNA)-mediated Ell3 knockdown in mouse ES cells.
About 887 genes are significantly downregulated with an FDR
<0.05 and fold change >1.5 in Ell3-depleted ES cells, including
Sox9 and St3gal1 (Table S1). Gene ontology analysis demon-
strates that many of the Ell3 affected genes are involved in
developmental processes, such as anatomical structure devel-
opment, epithelium development, tube development, and
chordate embryonic development (Figure S2A). Many genes
involved in cell adhesion, cell communication, signal transduc-
tion, and response to chemical stimulus are also affected by
Ell3 knockdown.
In order to further investigate the extent to which Ell3 differen-
tially regulates the expression of specific classes of genes, we
first clustered the ChIP-seq enrichment profiles of the genes
nearest to the high-confidence Ell3 peaks based on the co-
occurrence of Pol II and the histone modifications H3K4me3,
H3K36me3, and H3K27me3. The 3,272 genes proximal to
Ell3-occupied peaks were clustered into three major groups,
A–C (Figure 2A). Group A (or ‘‘active’’) genes show enrichment
of Pol II and the active transcription marks H3K4me3 and
H3K36me3 and have the highest transcription levels (Figure
2B). Stem cell self-renewal genes, such as Sox2 and Nanog,
fall into this group (Figures 1C and 2C). Group B (or ‘‘basal’’)
genes, such as Rere and Bbx genes (Figures 2D and S2B), are
characterized by low or no detectable levels of histone modifica-
tions H3K36me3 and H3K27me3 and by low transcription
(Figure 2B). Group C genes, such as St3gal1 and Sox9 genes
(Figures 2E and S2C), which are marked by both H3K27me3
and H3K4me3, have an even lower ‘‘constrained’’ expression
level, as assayed by RNA-seq (Figure 2B). Group C contains
many of the previously described ‘‘bivalent’’ genes that are
marked by both H3K4me3 and H3K27me3 in embryonic stem
cells and are proposed to be in a poised state (Bernstein et al.,
2006). Gene ontology analysis shows that Group C is enriched
for genes involved in various developmental processes
(Figure S2D).
We next asked how the different groups of Ell3-associated
genes were affected by loss of Ell3. Gene expression MA plots
show that depletion of Ell3 reduces the expression of a subset
of group B and C genes but has minor effects on group A genesCell 152, 144–156, January 17, 2013 ª2013 Elsevier Inc. 145
Figure 1. Ell3 Occupies Enhancer Regions in Mouse Embryonic Stem Cells
(A) Pie chart showing the percentages of the Ell3 peaks that overlap with a transcription start site (TSS), within a gene, and upstream or downstream of the nearest
gene.
(B) Upstream and downstream peaks were further categorized by their distance to the nearest TSS.
(C) Ell3 colocalizes with p300 at enhancer regions. Genome browser track examples for the occupancy profiles: Ell3; transcription factor, Oct4; histone modi-
fications, H3K4me1, H3K27ac, H3K4me3, and H3K27me3; transcriptional coactivator, p300 (Creyghton et al., 2010; Marson et al., 2008; Mikkelsen et al., 2007).
(D) Binding profiles for Ell3, p300, H3K4me1, and H3K4me3 are shown for regions 50 kb upstream and downstream of all 5,253 high-confidence Ell3 peaks. Color
indicates enrichment at FDR <0.05. The majority of the Ell3-occupied regions are also enriched for the enhancer signature of p300 with H3K4me1, but not
H3K4me3 (Creyghton et al., 2010).
(E and F) Profiles of p300, H3K4me1, and H3K4me3 centered on Ell3 peaks show 5 kb around the Ell3 peak summit. The majority of Ell3 peaks (4,806) are found
upstream or downstream of a TSS, and these are coenriched for p300 and H3K4me1. In contrast, only 447 Ell3 peaks are found at a TSS that is enriched for p300
and H3K4me3.
(G) Functional annotation of Ell3-bound non-TSS peaks, as reported by GREAT (McLean et al., 2010), indicates enrichment for developmental processes. The
logarithmic x axis values correspond to binomial FDR-corrected –log10 q values.
See also Figure S1.(Figures 2F–2H). For example, although Ell3 occupies the active
enhancer regions of the critical stem cell self-renewal genes
Sox2, Nanog, and Pou5f1 (Figures 1C and 2C and data not
shown), Ell3 is largely dispensable for their expression (Figures
2C, S2E, and S2F) and for stem cell self-renewal (Figure S2G).
Furthermore, fold changes of expression among groups A–C
were directly compared, indicating that group C genes are the
most significantly affected by Ell3 (Figure S2H). For example,146 Cell 152, 144–156, January 17, 2013 ª2013 Elsevier Inc.the expression level of the group C gene St3gal1 is dramatically
reduced after Ell3 knockdown when compared with the group A
gene Nanog and the group B gene Rere (Figures 2C–2E).
Therefore, enhancer-associated Ell3 mainly affects the expres-
sion of a subset of the ‘‘constrained’’ genes that are enriched
for developmental processes, with a subtle effect on the basal
expression of the group B genes that are involved in cellular
processes (Figures S2D and S2H).
Figure 2. Ell3 Binding to Enhancers Is Required for the Expression of a Subset of Neighboring Genes
(A) Cluster diagram of the 3,272 nearest genes to high-confidence Ell3 peaks. ChIP-seq enrichment profiles of Ell3-associated genes for the factors or chromatin
modifications indicated were K means clustered into three groups, (A, active), (B, basal), and (C, constrained), which are mainly distinguished by the profiles of
H3K36me3 and H3K27me3 in ES cells (Marson et al., 2008; Mikkelsen et al., 2007).
(B) Gene expression (RPKM) analyses of the Ell3 nearest group A–C genes. Only genes with statistically sufficient coverage by RNA-seq are shown
(see Experimental Procedures).
(C–E) Genome browser track examples of group A–C genes. Ell3 colocalizes with p300 at enhancer regions. RNA-seq analysis shows reduced expression of the
group C gene St3gal1 upon Ell3 knockdown.
(F–H) Gene expressionMAplots show the differential expression of group A–Cgenes in Ell3-depleted ES cells versus control cells. Significantly changed genes as
reported by Cufflinks are shown in color. Dotted lines indicate log2 fold changes of 0.5 and 0.5.
See also Figure S2 and Table S1.Ell3 Regulates Pol II Occupancy at Promoter-Proximal
Regions of Neighboring Genes
Ell3 was initially identified as a member of the ELL family of RNA
Pol II elongation factors, which can increase the transcriptionelongation rate catalyzed by Pol II (Miller et al., 2000). ELL family
members can directly interact with Pol II and are proposed to
facilitate the proper alignment of the 30 terminus of the nascent
transcript with the Pol II active site (Elmendorf et al., 2001;Cell 152, 144–156, January 17, 2013 ª2013 Elsevier Inc. 147
Figure 3. Ell3 Regulates Pol II Occupancy at Promoter-Proximal Regions of Neighboring Genes
(A–C) Genome browser profiles of Pol II occupancy in control and Ell3-depleted cells. Pol II levels are reduced at the Rere and St3gal1 genes but are not
significantly altered on the Nanog gene.
(D–G) Average Pol II occupancy plots for the top 1,000 highly expressed genes and Ell3 nearest genes from the Figure 2A group analysis. Rank-normalized
average Pol II levels within 5 kb of the TSS are shown in control (black line) and Ell3 knockdown (red line) ES cells. Pol II is reduced at the TSS region of Ell3-
associated genes, with strong effects on group C genes.
See also Figure S3.Shilatifard et al., 2003). Because Ell3 binding to enhancers is
required for the proper expression of a subset of group B and
C genes (Figure 2), we asked whether Ell3 is required for the
proper occupancy of Pol II at its nearest genes by performing
Pol II ChIP-seq after Ell3 knockdown. Loss of Ell3 leads to reduc-
tion of Pol II in many group C genes, such as Sox9 and St3gal1,
and group B genes, such asRere andBbx, with a lesser effect on
group A genes, like Nanog (Figures 3A–3C and S2B–S2C). The
effect on promoter-proximal Pol II occupancy is specific to Ell3
knockdown, as the depletion of the related protein Ell2 does
not result in changes in Pol II occupancy at these genes
(Figure S3A).
In order to further investigate whether Ell3 differentially
regulates the Pol II occupancy in groups A–C genes genome
wide, we directly compared the occupancy levels of Pol II at
promoter-proximal regions of genes nearest to Ell3-bound
peaks in control and Ell3-depleted ES cells. Compared with
groups A and B, group C genes show the largest fold reduction
in Pol II occupancy (Figures 3D–3G). We note that group C
genes are expressed at a very low level, and it therefore may
be easier to observe a larger fold change in Pol II occupancy
and expression after Ell3 RNAi than at highly expressed genes.
However, our data suggest that, during the process of gene
activation, genes may achieve a state at which they no longer
require Ell3 at their enhancers for themaintenance of expression.
To rule out the possibility that Ell3 might affect the assembly
of the basal transcriptional machinery at an early stage, the level
of the basal factor TFIIB loading was also examined in Ell3-148 Cell 152, 144–156, January 17, 2013 ª2013 Elsevier Inc.depleted cells (Figures S3B and S3C). We find that the basal
transcription factor TFIIB is properly recruited to the promoter
regions of the group C genes after Ell3 knockdown. Thus,
Ell3’s presence at enhancers appears to be specific for estab-
lishing Pol II at neighboring genes.
Ell3-Dependent Enhancer-Promoter Communication
Requires the Cohesin Complex
One of the well-accepted models for the regulation of neigh-
boring gene activities by enhancers is enhancer-promoter loop-
ing (Bulger and Groudine, 2011; Li et al., 2012; Lieberman-Aiden
et al., 2009; Montavon et al., 2011). It has recently been shown
that the cohesin and Mediator complexes occupy both the
enhancer and promoter regions, promoting loop formation
between the enhancer-promoter pairs at active genes (Kagey
et al., 2010). Interestingly, the cohesin and Mediator complexes
are found on many of the Ell3-bound enhancers, including the
Lefty1, St3gal1, as well as the DNase I hypersensitive site HS2
enhancer of the b-globin locus, which is known to be regulated
bycohesin in erythroid cells (Houet al., 2010) (Figure 4A).b-globin
genes are completely silent genes in EScells, suggesting that co-
hesin and Mediator complexes might also function in enhancer-
promoter communication at both poised and inactive genes.
To explore whether the cohesin complex is also required for
the establishment of promoter-proximal Pol II at Ell3-responsive
genes, Pol II occupancy was first examined in cohesion-subunit-
depleted cells. The Smc1a and Smc3 proteins are significantly
reduced by the Smc1a and Smc3 shRNAs, respectively
Figure 4. Ell3-Dependent Enhancer-Promoter Communication Requires the Cohesin Complex
(A) Genome browser profiles for Ell3, p300, cohesin (Nipbl, Smc1(a), and Smc3), Mediator components (Med1 and Med12), and Ctcf (Kagey et al., 2010). Ell3 is
found to colocalize with cohesin at sites that are enriched for Mediator and have low Ctcf occupancy (blue boxes). Ell3 is not enriched at cohesin sites that have
high Ctcf and low Mediator occupancy (green box).
(B) Knockdown of cohesin components Smc1a or Smc3 does not affect cellular Pol II levels. The unphosphorylated (8wg16 antibody), Ser5-phosphorylated
(H14), and Ser2-phosphorylated (H5) forms of RNA Pol II levels remain unchanged upon the knockdown of the cohesin components. Triangles indicate increasing
amounts of cell lysates. Tubulin serves as a loading control.
(C) Knockdown of the cohesin components reduces the promoter-proximal Pol II occupancy at many Ell3-responsive genes. Histone H1 (Histh1d) and a-globin
(Hba2) serve as highly expressed and nonexpressed control genes.
(D) Knockdown of Smc3 reduces Ell3 occupancy at the enhancer regions of Ell3-responsive genes. Ell3-bound putative enhancer regions were chosen based on
the co-occupancy with p300, cohesin, and H3K4me1. The Hba2 gene serves as a nontranscribed control gene.
Error bars indicate standard deviation of three independent measurements.
See also Figure S4.(Figure 4B). Smc3 knockdown also leads to a reduction of the
protein levels of Smc1a, but not the Smc1a mRNA levels,
suggesting that Smc3 affects Smc1a protein stability (Figures
4B and S4A). The depletion of the cohesin complex does not
have much of an effect on global Pol II levels, whether looking
at the total, phosphorylated, or unphosphorylated forms (Fig-
ure 4B). However, Pol II occupancy at promoters of the genes
nearest to Ell3-bound peaks was greatly reduced after cohesin
knockdown, as shown by ChIP-qPCR (Figure 4C), indicating
an important role of the cohesin complex in establishing
promoter-proximal engaged Pol II at Ell3 target genes.
To further assess whether the role of Ell3 in promoter-proximal
Pol II occupancy is mediated through the cohesin complex, wetested Ell3-binding profiles in the cohesin-depleted cells. The
results revealed that depletion of the cohesin complex (Smc3
knockdown) also greatly reduces Ell3 occupancy at the
enhancer regions (Figure 4D). This is not due to the reduced
expression of the Ell3 gene, as quantitative RT-PCR shows
that Ell3 mRNA levels remain unchanged after Smc3 knockdown
(Figure S4B). Therefore, the cohesin complex appears to play
a role in the localization/stability of Ell3 on these enhancers
and through chromatin looping mediates Ell3’s effect on RNA
Pol II at promoter-proximal regions.
To further explore whether Ell3’s binding at enhancers could
stabilize enhancer-promoter interactions, we performed a chro-
mosome conformation capture (3C) assay by anchoring on anCell 152, 144–156, January 17, 2013 ª2013 Elsevier Inc. 149
Figure 5. Ell3 Binding at Enhancers Is Required for Future Gene Activation by SEC
(A–D) qRT-PCR analyses of the activation time course of four bivalently marked genes in the control and Ell3 knockdown EBs. Control and Ell3 knockdown
ES cells were induced to form EB for 0 (EB0), 3 (EB3), 5 (EB5), and 10 (EB10) days, as indicated. The expression levels were normalized to Actb.
(E) Schematic model for Ell3 prebinding at enhancers primes future gene activation by SEC.
(F) Ell2 is recruited to the promoters of Ell3-regulated genes in 5 day EBs, as shown by ChIP. The Hba gene serves as a nontranscribed control gene.
(G) Ell2 is required for the activation of many of the genes regulated by Ell3 in EBs. The control and Ell2 knockdown ES cells were induced to form EBs in the petri
dishes for 5 days before the qRT-PCR analyses. The expression levels were normalized to Actb.
(H) Ell3 binding to enhancers is required for the activation of Hox genes by retinoic acid (RA). Control and Ell3 knockdown ES cells were untreated (control) or
treated with RA for 24 hr (RA24) before harvesting for the qRT-PCR analysis.
(I) Ell3 is required for the recruitment of SEC (Aff4) to theHoxa1 gene after RA treatment. ChIP signal is normalized to the nontranscribedHba2 gene. The error bars
indicate standard deviation of three independent measurements.Ell3-binding site at the Hoxa locus. We observe a broad domain
of interactions at the Hoxa locus in the ES cell state, consistent
with the published Hi-C data reporting this region as encom-
passing a topological domain (Figures S4C–S4E) (Dixon et al.,
2012). Interestingly, after 24 hr of RA treatment, these interac-
tions become more local and specific, and this transition in
interactions requires Ell3 (Figure S4F).
Ell3 Binding at Enhancers Is Required for Future Gene
Activation by SEC
Many of the bivalent genes can be activated during differentia-
tion (Bernstein et al., 2006). Because the Ell3-bound group C is150 Cell 152, 144–156, January 17, 2013 ª2013 Elsevier Inc.enriched for bivalently marked genes, we asked whether their
induction requires Ell3. Embryoid bodies (EBs) were derived
from shRNA-mediated control and Ell3 knockdown of ES cells
for 3, 5, and 10 day periods. As shown by quantitative RT-PCR
analyses, the activation of Sox9, Irx3, St3gal1, and Foxp2 was
significantly reduced in the Ell3-depleted EBs, especially in day
5 and day 10 EBs (Figures 5A–5D). Thus, apart from Ell3’s role
in ES cells in regulating the constrained expression of its
proximal group C genes, Ell3 also seems to be required for
their further transcriptional activation during differentiation.
Previously, we demonstrated that Ell2 within SEC plays impor-
tant roles in the activation of developmentally regulated genes in
ES cells (Lin et al., 2011). Many of these Ell2/SEC-responsive
genes contain engaged Pol II at their promoter-proximal regions
in the undifferentiated state. Therefore, we asked whether Ell2/
SEC is required for the activation of Ell3-regulated genes (Fig-
ure 5E). Chromatin immunoprecipitation in day 5 EB samples
shows that Ell2 is indeed recruited to the promoter regions of
the Sox9 and St3gal1 genes during differentiation (Figure 5F).
Furthermore, qRT-PCR analysis of day 5 Ell2-depleted EBs
revealed that Ell2 is also required for the activation of many
Ell3-responsive genes, including Sox9, St3gal1, and Foxp2,
during development (Figure 5G). Taken together, these results
suggested that Ell3 might function upstream of Ell2/SEC in tran-
scriptional programs during development.
To further investigate whether prebinding of Ell3 to enhancers
is essential for future gene activation through recruitment of
SEC, we first examined the requirement of Ell3 for the activation
of Hoxa1 by retinoic acid (RA), a gene activated by SEC (Lin
et al., 2011). Quantitative RT-PCR analysis indicates that the
activation of Hoxa1 by RA is reduced after Ell3 knockdown (Fig-
ure 5H). In addition, depletion of Ell3 impairs the recruitment of
Aff4, the central factor of SEC, to the Hoxa1 promoter after
24 hr of RA treatment (Figure 5I). Our previous biochemical
studies indicated that ELL3 can interact with AFF4 and P-TEFb
to form a complex similar to ELL2-containing SEC in 293 cells
(Lin et al., 2010). We have also found that Ell3 can interact with
Aff4 and P-TEFb when overexpressed in ES cells (data not
shown). Therefore, we propose that Ell3’s binding to enhancers
is required for the full assembly of SEC on the promoter of genes
and, thus, future gene activation by SEC at the Ell3 target genes.
Ell3 Is Essential for Stem Cell Specification
Interestingly, in addition to the above-mentioned group A–C
genes, some inactive, or dormant, lineage-specific genes are
also associated with Ell3/p300-bound enhancers but have no
detectable Pol II, H3K4me3, andH3K36me3 in their transcription
units. For example, Ell3 and p300 are present at the above-
mentioned well-characterized HS2 enhancer element of the
b-globin locus, which is silent in ES cells (Figure 4A and data
not shown). Therefore, we consider HS2-like enhancers to be
in an ‘‘inactive/dormant state,’’ or group D.
To explore whether Ell3 is required for the induction of lineage-
specific genes, we measured transcript levels in the embryoid
bodies derived from control and Ell3-depleted ES cells. Our
analyses demonstrate that many endoderm markers (Foxa2,
Gata4, and Gata6), mesoderm markers (Gsc, T, and Fgf8), and
ectoderm-specific genes (Kcnc1, Gli1, and Olig3) are signifi-
cantly downregulated in Ell3-depleted EB samples compared
with control EB samples (Figures 6A–6C). Examination of Ell3
occupancy shows that Ell3 associates with many of the inactive
or poised enhancers of these lineage-specific genes (Figure S5).
Moreover, many of these genes do not contain detectable Pol II
at their promoter-proximal regions (Figure S5). Further RNA-seq
analysis on the differentiated day 5 EBs indicates that 2,862
genes were upregulated with an FDR <0.05 and fold change
>1.5 (Table S2). Of these, 510 contain Ell3 at their enhancers in
the ES state (Table S2), suggesting the involvement of Ell3 in
stem cell differentiation. Many of these genes with Ell3-bound
enhancers are required for neuronal specification, includingSlit3, Pax6, Ephb2, Ephb3, Sema6a, Ank3, Nfasc, Ripply2,
Slitrk5, and Klf7. Therefore, we next assessed the effect of Ell3
knockdown on neural induction by retinoic acid in ES-derived
embryoid bodies. The b-tubulin-III-positive neural fibers are
significantly reduced in the Ell3-depleted EBs compared with
the control EBs (Figure 6D). Taken together, these results sug-
gest that enhancer-associated Ell3 is essential for stem cell
specification.
Ell3 Is Present on the Chromatin of Germ Cells
The presence of Ell3 at enhancers in ES cells of many dormant
lineage-specific genes (both group C and group D genes) raises
the question of at what stage Ell3 is recruited to mark these
enhancers. Interestingly, our previous northern blot analyses
indicated that Ell3 is highly enriched in testes (Miller et al.,
2000). We therefore performed immunofluorescence staining
of mouse sperm and observe that Ell3 localizes to sperm nuclei
(Figure 7A). Immunogold labeling of Ell3 in mouse sperm by
Ell3 antibodies raised against either the N or C termini of Ell3
further validates the nuclear localization of Ell3 in sperm (Figures
7B and S6). Interestingly, we also detect Pol II in sperm nuclei
by immunogold labeling (Figure 7B). Whereas Ell3 N- and
C-terminal antibodies colocalize well (within 5–10 nm) in sperm
nuclei, antibodies to Ell3 and Pol II appear to occupy different
regions in the sperm cell nucleus (Figure 7B).
DISCUSSION
Regulatory elements play a central role in establishing promoter-
proximal engaged Pol II, as previously demonstrated for the
Drosophila Hsp70 gene and the murine Ig kappa gene (Lee
et al., 1992; Levine, 2011; Raschke et al., 1999). The deletion
of the GAGA element upstream of the Hsp70 core promoter or
the deletion of the intron enhancer and C regions of the Ig
kappa gene abolished the occupancy of Pol II at their respective
promoters. However, whether there are enhancer-associated
factors that are more generally required for the establishment
of Pol II at developmental genes was not known. Here, we report
that the elongation factor Ell3 preferentially binds to enhancers,
mediates the promoter-proximal occupancy of RNA Pol II at
many of the developmentally regulated genes in mouse embry-
onic stem cells, and is required for their future activation during
stem cell specification (Figures 7C–7E). The Ell3-mediated
enhancer function in promoter-proximal occupancy by Pol II
requires the cohesin complex, revealing a key step in the estab-
lishment of the ‘‘paused Pol II’’ state that is pervasive in ES
cells and the regulation of gene activation during early embryo
development.
A Model for the Enhancer-Associated Ell3 in the
Coordinated Induction of Transcription by SEC
Cohesin and mediator complexes were initially shown to be
involved in the enhancer-promoter communication at active
genes (Newman and Young, 2010). Interestingly, cohesin and
mediator are also present at Ell3-bound ‘‘inactive’’ enhancers
in ES cells, such as the b-globin locus (Figure 7C). It is possible
that during differentiation, lineage-specific transcription factors
such as GATA1 and NFE2 (Bulger and Groudine, 2011; DengCell 152, 144–156, January 17, 2013 ª2013 Elsevier Inc. 151
Figure 6. Ell3 Is Essential for Stem Cell Specification
(A–C) qRT-PCR analyses of the activation kinetics of lineage-specific genes in control and Ell3 knockdown EBs. Control and Ell3 knockdown ES cells were
induced to form EB for the indicated time points. Expression levels were normalized to Actb. The error bars indicate standard deviation of three independent
measurements.
(D) Ell3 is essential for the proper neural differentiation of mouse ES cells. The 5 day differentiated EBs from control and Ell3 knockdown ES cells were further
differentiated into neural cells by exposure to retinoic acid for 14 days. Neural differentiation competence was visualized by immunostaining for the neuronal
marker class III b-tubulin (b-tub III, green) and the DNA marker DAPI (blue).
See also Figure S5 and Table S2.and Blobel, 2010) can interact with enhancer and promoter
elements to help bridge cohesin and mediator communication
with Pol II at the promoter, a process that can be further stabi-
lized by Ell3 (Figure 7D). Setting up looped chromosomal
domains could form a constrained transcriptional state associ-
ated with bivalent mark of H3K4 and H3K27 methylation (Bern-
stein et al., 2006) in a progenitor cell before full transcriptional
activation. In addition, we find that many of the genes showing
reduced paused Pol II after Ell3 knockdown were also in our
Group B, which lacked the bivalent mark. Group B genes may
constitute a transition state between constrained expression of
bivalently marked genes and activated transcription (Cui et al.,
2009; Zhang et al., 2012).
The presence of Ell3 could be particularly important at genes
requiring an Ell2 version of SEC to release poised Pol II through
phosphorylation of DSIF/NELF and the Pol II CTD (Figure 7E)152 Cell 152, 144–156, January 17, 2013 ª2013 Elsevier Inc.(Lin et al., 2011; Luo et al., 2012). Upon differentiation, Ell2 within
SEC is recruited to the genes with Ell3-occupied enhancers
and is required for their activation. This can be attributed to the
function of Ell2 within SEC in releasing paused Pol II (Lin et al.,
2011). Therefore, in certain circumstances, the ability of Ell2
and Ell3 to form similar and dynamic complexes could underlie
a mechanism for the transition from Ell3’s presence at poised
enhancers in ES cells to Ell2’s role in the release of paused Pol
II during gene activation. Enhancer-promoter interactions could
facilitate local assembly and/or recruitment of functional SEC
complexes for rapid but regulated gene activation. This model
is supported by observations that: (1) Ell3 binding to enhancers
is required for the recruitment of SEC during differentiation; (2)
Mediator occupies Ell3-bound enhancers; and (3) the MED26
subunit is required for the recruitment of SEC to the HSP70
and MYC genes (Kagey et al., 2010; Takahashi et al., 2011).
Figure 7. Ell3 and Pol II Are Found in Germ Cell Nuclei
(A) Immunofluorescence staining of Ell3 in mouse sperm. Mouse sperm were fixed and stained with antibodies raised against the C terminus of mouse Ell3 and
were counterstained with DAPI.
(B) Immunogold labeling of Ell3 and Pol II in mouse sperm. Mouse spermwere fixed, cryosectioned, and double stained with Ell3 N-terminal and Pol II antibodies.
Both Ell3 (red arrow, 6 nm gold particles) and Pol II (blue arrow, 12 nm gold particles) localize to the nucleus of the sperm. Colocalization of Ell3 and Pol II was
largely not observed compared to the colocalization of the N- and C-terminally raised Ell3 antibodies, which are frequently found within 5–10 nm of each other
(see also Figure S6).
(C–E) Amodel for the enhancer-associated Ell3 in coordinated transcriptional induction by SEC. H3K4me1, p300, Mediator, and cohesin can be foundwith Ell3 at
inactive, poised, and active enhancers.
(C) At inactive/dormant enhancers, Ell3 is prebound with Mediator and cohesin, but Pol II is not found at the promoter.
(D) In the poised state, a subset of developmental regulators is in a constrained state of expression, with both H3K4me3 and H3K27me3 at the promoter. Pol II’s
presence at these promoters depends on the interactions between cohesin, Mediator, and Ell3.
(E) Upon receiving the proper activating signals, SEC is recruited and stabilized at the promoter region through interaction with Mediator and Ell3. SEC phos-
phorylates the RNA Pol II CTD, Spt5, and Nelf, thus resulting in the release of Pol II and gene activation.Ell3 as a Candidate for Priming Future Gene Activation
The activation of the zygotic genome, leading to the control of
development by both the paternal and the maternal genomes
is a key event during the maternal-to-zygotic transition (MZT)
following fertilization. Recent studies have identified the zinc
finger protein Zelda as a factor that marks the promoter and
enhancer regions of both active and inactive genes in the
Drosophila early zygotic genome (Harrison et al., 2011; Liang
et al., 2008; Nien et al., 2011). The association of Zelda with inac-
tive genes is required for their future activation, indicating an
essential role of Zelda as a ‘‘pioneer transcription factor’’ (Harri-
son et al., 2011). However, how Zelda binding at the promoter
and enhancer regions of inactive genes regulates their future
expression and how the cofactors working together with Zelda
to activate the zygotic genome remain largely unknown.In this study, we found that mammalian Ell3 not only binds to
the enhancer regions of active genes, but also marks the
enhancers of inactive genes in mouse embryonic stem cells,
many of which are lineage-specific genes, such as b-globin,
Gsc, and T. The marking of Ell3 at the inactive enhancers of
mammalian cells is required for the future activation of their
associated genes, analogous to what has been reported for
Zelda in Drosophila embryogenesis. There is no Zelda homolog
known outside of arthropods (Liang et al., 2008), and the mech-
anism by which Ell3 is so generally recruited to enhancers of
genes with varying chromatin states and transcriptional
activities is currently unknown. Instead of a single Zelda in mam-
mals, there could conceivably be a large family of zinc finger
proteins that can recognize various enhancer sequences and
help to recruit Ell3.Cell 152, 144–156, January 17, 2013 ª2013 Elsevier Inc. 153
Intriguingly, both Ell3 and Pol II seem to be associated in the
nuclei of mouse sperm but do not colocalize, which might be
explained if Ell3 was occupying inactive enhancers and Pol II
was present at TSS regions, similar to what we observe by
ChIP-seq analyses in the ES cell state. These data suggest
that Ell3 might serve as an epigenetic marker in germ cells by
bookmarking the inactive enhancers of genes for future activa-
tion in the embryo. Although sperm chromatin is highly com-
pacted due to replacement of histones with protamines during
spermatogenesis, it was recently discovered that histones can
mark promoters of developmentally regulated genes and that
histone modifications at these promoters are predictive of early
developmental expression (Hammoud et al., 2009). Our work
suggests that it might also be possible that regulatory regions
of key developmental genes are bound by transcription factors
such as Ell3 or by RNA Pol II. ChIP-sequencing analyses of
Ell3 and Pol II in sperm and oocytes will be required to test this
model and could reveal interesting information on mechanisms
of epigenetic inheritance.
A Potential Role of Ell3 in Cancer Pathogenesis
Many of the SEC components are among the most frequent
MLL (myeloid/lymphoid or mixed-lineage leukemia) transloca-
tion partners found in human AML and ALL leukemia patients
(Mohan et al., 2010; Smith et al., 2011a). SEC is broadly recruited
to MLL chimera target genes in both MLL-SEC and MLL-non-
SEC-translocated leukemic cells (Lin et al., 2010; Yokoyama
et al., 2010). Many of the commonly and highly misregulated
genes by different MLL chimeras, including the Runx1, Ebf1,
Cdk6, Meis1/2, and Hoxa cluster genes (Dawson et al., 2011;
Krivtsov and Armstrong, 2007; Lin et al., 2010), are occupied
by Ell3 on their enhancers in the ES state. It is likely that the
MLL chimeras bypass the tight regulation of these ELL3-associ-
ated genes in hematopoietic cells, contributing to leukemogen-
esis. Therefore, investigating the extent to which Ell3 functions
in other stem/progenitor cells could have implications in SEC
function in other developmental pathways and the misregulation
of SEC in disease.
EXPERIMENTAL PROCEDURES
ES Cell Culture and Differentiation
Mouse embryonic stem cells (KH2 and V6.5) were cultured on irradiated
mouse embryonic fibroblast (MEF) feeder layers in 0.1% gelatin-coated tissue
culture flask. Cells were grown in DMEM (D6546, Sigma) supplemented with
15% ES-certified fetal bovine serum (Hyclone), 2 mM L-glutamine, 0.1 mM
nonessential amino acids, 0.1 mM b-mercaptoethanol, and recombinant LIF
(Millipore). For ChIP and RNA analysis, cells were grown for one passage off
feeders on tissue culture plates for 30min. Embryoid bodies (EBs) were formed
by culturing 150,000/ml ES cells in ES medium without LIF (ES differentiation
medium) on nonadhesive bacteriological petri dishes for the indicated days
(Kurosawa, 2007). Media were changed daily after 2 days. For neural differen-
tiation, day 5 EBs were plated on laminin-coated 6-well tissue culture plate in
ES differentiation medium with 1 mM all-trans retinoic acid (Sigma) for an
additional 14 days. Media were changed every other day. On day 14, the
RA-treated EBs were immunostained with anti-b-Tubulin III (Covance).
Electron Microscopy
Sperm were fixed in 2% paraformaldehyde/0.01% glutaraldehyde (PBS) and
embedded in 3% gelatin. Samples were infiltrated with 2.3 M sucrose at 4C154 Cell 152, 144–156, January 17, 2013 ª2013 Elsevier Inc.overnight and then mounted on aluminum stubs, frozen, and sectioned. Thin
sections (50–70 nm) were picked up in drops of 2.3 M sucrose and collected
on formvar and carbon-coated mesh grids. After blocking in 1% BSA in
PBS, the sections were incubated with primary antibodies and subsequently
incubated with secondary antibody conjugated to 6 nm and/or 12 nm gold
particles (Jackson ImmunoResearch Laboratories, Inc.). The sections were
fixed in 1% glutaraldehyde and stained with ice-cold 0.4% uranyl acetate/
1%methyl cellulose (pH 4) and dried. The samples were viewed in a FEI Tecnai
transmission electron microscope operated at 80kV.
Quantitative RT-PCR and Total RNA-Seq Analysis
ES cells (V6.5) were infected with lentivirus carrying either nontargeting shRNA
or Ell3 shRNA in the presence of 8 mg/ml of polybrene (Sigma). At 24 hr later, ES
cells were selected with 2 mg/ml of puromycin for an additional 48 hr and then
were grown one passage off feeders for 30 min before harvest. Total RNA was
isolated with the RNeasy (QIAGEN) kit, treated with DNase I (NEB), and
repurified with RNeasy. cDNAs were synthesized with High Capacity RNA-
to-cDNA Kit from Applied Biosystems. The expression levels were measured
with iQ SYBR Green Supermix from Bio-Rad on MyIQ (Bio-Rad). Relative
expression to housekeeping genes was calculated assuming 2-fold primer
efficiencies. For RNA-seq, total RNA was depleted of rRNA using Ribozero
(Illumina) before library preparation using Tru-seq (Illumina). Details of RNA-
seq data analysis are provided in the Supplemental Information.
Chromosome Conformation Capture Assay
The 3C assaywas performed as previously described withminormodifications
(Hage`ge et al., 2007). In brief, 13 107 cells were crosslinked with 2% of para-
formaldehyde at room temperature for 10 min, followed by glycine quenching
and cell lysis. The nuclei were digested with HindIII overnight at 37C and
then ligated with T4 DNA ligase at 16C for 4 hr. DNA was purified by
phenol-chloroform extraction. Primer efficiencies were monitored by serial
dilution. Digestion efficiencies were examined by primer pairs amplifying
genomic regions spanning or devoid of HindIII sites. A bacterial artificial chro-
mosome (BAC) containing the entire Hoxa locus (RP23-20F21) was digested
with HindIII and religated to prepare the control template. To compare results
between samples, the 3C signals were normalized to a control locus Ercc3.
ChIP-Seq
53 107 cells were used per ChIP assay according to the previously described
protocol (Lee et al., 2006). In brief, cells were crosslinked with 1% paraformal-
dehyde for 10 min at room temperature; crosslinking was quenched by
glycine. Fixed chromatin was sonicated and immunoprecipitated with a
specific antibody. Libraries were prepared with Illumina’s ChIP-Seq sample
prep kit for the further next-generation sequencing. ChIP sequencing and
other data analyses can be found in the Extended Experimental Procedures.
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ChIP-seq and expression data have been deposited at GEO under the
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